Director, Portfolio & Strategic Operations- Immunology and Cardiovascular (ICV) Therapeutic Area (TA), Clinical Development at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Experience managing leadership team (LT) meetings and developing yearly objectives, priorities, actionable plans, progress tracking, risk mitigation, and contingency planning
Ability to plan workshops, manage team effectiveness, and incorporate LT commitments into operations rhythm
Skills in supporting TA strategy development, strategic initiatives, and inputs for corporate goals and objectives
Expertise in developing engagement plans, managing interactions (e.g., Town Halls, Team Touch Points), and strategic business operations including quarterly budget projections, resource requirements, risk escalation, and goal tracking
Proficiency in tracking resourcing, occupancy strategy with HR, preparing Congresses and Business reviews, and developing leadership messaging (e.g., change management, communications cascade)
Capability to coordinate with stakeholders from Clinical Development, Development, Commercial, BMS leadership, and board of directors
Experience supporting special initiatives, Chief of Staff community, P&SO capability development, clinical strategy creation/evolution, and coordination with Clinical Center of Excellence (CCoE)
Knowledge of portfolio management, assessing status/risks/challenges, providing insights/analytics for decisions, and partnering with PI&R, Commercial, BI&T on prioritization, governance, resource management, and financial planning

Responsibilities

Manage ICV TA Clinical Development Head LT meetings
Help develop yearly objectives and priorities for ICV Clinical Development, translate into actionable plans, track progress, ensure risk mitigation and contingency planning
Plan workshops, manage team effectiveness, incorporate LT commitments into operations rhythm
Support development of TA strategy and strategic initiatives; oversee TA inputs for DD annual corporate goals
Develop engagement plans and manage ICV Clinical Development Head interactions/engagements (e.g., Town Halls, Team Touch Points)
Manage ICV TA Clinical Development strategic business operations, drive quarterly budget projections, resource requirements, risk escalation, goal tracking; track resourcing/occupancy with HR
Lead preparation of Congresses and Business reviews; develop leadership messaging
Coordinate with Clinical Development, Development, Commercial stakeholders to develop priorities; engage with BMS LT and board
Support special initiatives in ICV TA and DD; contribute to Chief of Staff community and P&SO initiatives
Support ICV TA Clinical Development Head in clinical strategy creation/evolution and coordination with CCoE
Support strategy execution and portfolio management (e.g., assess portfolio status, risks, challenges)
Partner with PI&R on portfolio insights/analytics, prioritization at governance forums, agenda triaging, and implementation
Drive early/late Drug Development portfolio prioritization/management processes (e.g., criteria alignment, resource management, financial planning) with PI&R, Commercial, BI&T
Partner with Commercial Portfolio Strategy for annual portfolio prioritization; collaborate on fit-for-purpose portfolio insights

Skills

Strategic Planning

Operations Management

Budgeting

Risk Mitigation

Team Leadership

Stakeholder Engagement

Clinical Development

Resource Management

Workshop Planning

Goal Tracking

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free